Search

Author/Creator Paralejas, P.

1. Dose ranging study of monalizumab (IPH2201) in patients with gynecologic malignancies: A trial of the Canadian Cancer Trials Group (CCTG): IND221. (December 2016)

Authors:
Tinker, A.; Hirte, H.; Provencher, D.; Butler, M.; Ritter, H.; Tu, D.; Paralejas, P.; Grenier, N.; Hahn, S.; Ramsahai, J.; Seymour, L.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search